SYMPICITY HTN-3's Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss
Experts grappled with how to understand the positive findings given that the trial missed its primary endpoint at 6 months.
Source: tctmd.com
Stay updated with breaking news from Global Symplicity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts grappled with how to understand the positive findings given that the trial missed its primary endpoint at 6 months.
Experts grappled with how to understand the positive findings given that the trial missed its primary endpoint at 6 months.